DMARD Therapy

DRUG3 trials

Sponsors

Zalicus, Amgen, Deraya University

Conditions

Early Rheumatoid ArthritisRheumatoid Arthritis

Phase 2

A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA

CompletedNCT00747214

ZalicusRheumatoid Arthritis

Start: 2004-11-30End: 2006-11-30Updated: 2014-05-20

A Randomized Clinical Trial Evaluating the Efficacy of Clinical Pharmacist Assistance Along With Pharmaceutical and Non-pharmaceutical Therapy in the Early Rheumatoid Arthritis

CompletedNCT07726355

Deraya UniversityEarly Rheumatoid Arthritis

Start: 2025-04-10End: 2026-06-01Updated: 2026-07-24

Phase 4

Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)

CompletedNCT01313208

AmgenRheumatoid Arthritis

Start: 2011-03-31End: 2013-05-31Updated: 2017-02-09

Related Papers

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy.

2015-03-0511 citations